Summary

About the company

Die Kernaktivität des Unternehmens Isanas AG ist die Entwicklung von neuen Therapien für schwere entzündliche Krankheiten, wie zum Beispiel Multiple Sklerose, Arthritis, Asthma und andere.

AI-generated

Knowledge

No knowledge articles yet

Once Capsa SANIGANT GmbH claims this profile, we will publish editorial articles and case studies together here.

Get started

Comparisons

Capsa SANIGANT GmbH in comparison

Soon

Industry comparisons are coming soon

We are preparing industry comparisons in which Capsa SANIGANT GmbH will be ranked by reviews, experience and specialisations.